200 Infos zu Johannes Zanzinger

15 Aktuelle Nachrichten

— ... Johannes Zanzinger de Boehringer Ingelheim et Katie Ellias du JDRF ... Advent France Biotechnology : Matthieu Coutet • Boehringer Ingelheim — ... Johannes Zanzinger de Boehringer Ingelheim et Katie Ellias du JDRF ... Advent France Biotechnology : Matthieu Coutet • Boehringer Ingelheim ...

— We welcome the new investors and look forward to working together in this important next phase for DiogenX,” said Johannes Zanzinger, Investment — We welcome the new investors and look forward to working together in this important next phase for DiogenX,” said Johannes Zanzinger, Investment ...

... Johannes Zanzinger, Investment Director at BIVF. “We are thrilled to continue our support of the DiogenX program in this important step towards the clinic Johannes Zanzinger, Investment Director at BIVF. “We are thrilled to continue our support of the DiogenX program in this important step towards the clinic ...

— ... Johannes Zanzinger, investment director at the Boehringer Ingelheim fund ... In preclinical studies it has shown an ability to regenerate insulin — ... Johannes Zanzinger, investment director at the Boehringer Ingelheim fund ... In preclinical studies it has shown an ability to regenerate insulin- ...

12 Profile in Sozialen Netzwerken

Johannes Zanzinger. Investor @ BI Venture Fund at Boehringer Ingelheim. Boehringer IngelheimUniversity of Hohenheim. Deutschland500+ Kontakte.

Sehen Sie sich das Karriere-Profil von Johannes Zanzinger (Deutschland) auf ... September – January (2 years 5 months) Biberach, Germany ...

Sehen Sie sich das berufliche Profil von Johannes Zanzinger (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach Es fehlt: premius

— We welcome the new investors and look forward to working together in this important next phase for DiogenX,” said Johannes Zanzinger, Investment — We welcome the new investors and look forward to working together in this important next phase for DiogenX,” said Johannes Zanzinger, Investment ...

3 Hobbys & Interessen

von J Zanzinger · · Zitiert von: 198 — Johannes Zanzinger,; Jürgen Czachurski, and; Horst Seller. 1 July | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol ... von J Zanzinger · · Zitiert von: 198 — Johannes Zanzinger,; Jürgen Czachurski, and; Horst Seller. 1 July | American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol ...

von J Zanzinger · · Zitiert von: 32 — JOHANNES ZANZINGER, JU¨ RGEN CZACHURSKI, AND HORST SELLER. I. Physiologisches Institut, Universität Heidelberg, D Heidelberg, Germany. Zanzinger ...

Recent bibliographic sampling of Johannes Zanzinger patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title): ...

3 Business-Profile

Johannes Zanzinger is an Investment Director at Boehringer Ingelheim Venture Fund. Johannes Zanzinger is an Investment Director at Boehringer Ingelheim Venture Fund.

Johannes ZANZINGER | Cited by | of Boehringer Ingelheim, Ingelheim am Rhein (BIRIT) | Read 30 publications | Contact Johannes ZANZINGER.

Ledelse/Administration. Raul Johannes Zanzinger, Fuldt ansvarlig deltager. Læs mere om firmaet på Proff. Proff logo. Til dig, der ejer firmaet. Vi ...

2 Firmen-Mitarbeiter

Board of Directors. Elias Papatheodorou, Chairman of the Board Prof. Dr. Lars Zender, University Hospital Tubingen Prof. Dr. Johannes Zanzinger, BIVF Dr ... Board of Directors. Elias Papatheodorou, Chairman of the Board Prof. Dr. Lars Zender, University Hospital Tubingen Prof. Dr. Johannes Zanzinger, BIVF Dr ...

Board of Directors · Prof. David Aviezer · Dr. Daguang Wang · Prof. Dr. Johannes Zanzinger · Prof. Eyal Gottlieb · Mr. Ohad Hammer · Dr. Pini Orbach · Dr. Denis ... › abo...

1 Persönliche Webseiten

Dr. Johannes Zanzinger. Biberach, Germany. Phone: + Dr. Monica Cheng. Ridgefield, CT, USA. › files › files

1 Infos zur Ausbildung

Johannes Zanzinger · Jürgen Czachurski · Bertram Offner · Horst Seller. Source Information. September 1994, Volume656(Issue2)Pages, p.353To Brain ... Johannes Zanzinger · Jürgen Czachurski · Bertram Offner · Horst Seller. Source Information. September 1994, Volume656(Issue2)Pages, p.353To Brain ...

3 Bücher zum Namen

... Callow, Una S. Ryan. III. ALTERED WASCULAR REACTIVITY ALTERED WASCULAR REACTIVITY IN CORONARY ARTERY DISEASE Johannes Zanzinger and ALTERED WASCULAR REACTIVITY.

Title, Untersuchung von Blutwerten und Herzfrequenz bei Zugochsen unter dem Aspekt der individuellen Leistungsfähigkeit. Author, Johannes Zanzinger.

13 Dokumente

Johannes ZANZINGER. Filter appointments. Filter appointments. Current appointments. Total number of appointments 1. Date of birth: February CENTAURI ... Johannes ZANZINGER. Filter appointments. Filter appointments. Current appointments. Total number of appointments 1. Date of birth: February CENTAURI ...

von J Zanzinger · · Zitiert von: 4 — JOHANNES ZANZINGER, KLAUS BECKER, AND MARTIN ROMETSCH. Institute for Applied Physiology, University of Freiburg, Freiburg (J.Z.) and. Institute for Animal ... von J Zanzinger · · Zitiert von: 4 — JOHANNES ZANZINGER, KLAUS BECKER, AND MARTIN ROMETSCH. Institute for Applied Physiology, University of Freiburg, Freiburg (J.Z.) and. Institute for Animal ...

... Johannes Zanzinger, PhD, Peter Widdowson, PhD, Mark Hawthorn, PhD, Geza Toth, PhD, Judit Farkas, PhD, Remo Guerrini, PhD, and David G. Lambert, PhD Johannes Zanzinger, PhD, Peter Widdowson, PhD, Mark Hawthorn, PhD, Geza Toth, PhD, Judit Farkas, PhD, Remo Guerrini, PhD, and David G. Lambert, PhD ...

von J Zanzinger · · Zitiert von: 66 — Johannes Zanzinger ,. Johannes Zanzinger. Department of Applied Physiology, University of FreiburgFreiburg, Germany: J ... von J Zanzinger · · Zitiert von: 66 — Johannes Zanzinger ,. Johannes Zanzinger. Department of Applied Physiology, University of FreiburgFreiburg, Germany: J ...

8 Wissenschaftliche Publikationen

von J Zanzinger · · Zitiert von: 63 — ... ventrolateral medulla in cats☆. Author links open overlay panel. Johannes Zanzinger , Jürgen Czachurski , Horst Seller. Show more. Add to Mendeley. Share. Cite. von J Zanzinger · · Zitiert von: 63 — ... ventrolateral medulla in cats☆. Author links open overlay panel. Johannes Zanzinger , Jürgen Czachurski , Horst Seller. Show more. Add to Mendeley. Share. Cite.

von E Initiative — Johannes Zanzinger. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach apl. Professuren. Page Name. Fachliche Ausrichtung / Institut. von E Initiative — Johannes Zanzinger. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach apl. Professuren. Page Name. Fachliche Ausrichtung / Institut.

von J Zanzinger · · Zitiert von: 26 — ... and receptor types. Author links open overlay panel. Johannes Zanzinger , Jürgen Czachurski , Bertram Offner , Horst Seller. Show more. Add to Mendeley. Share. von J Zanzinger · · Zitiert von: 26 — ... and receptor types. Author links open overlay panel. Johannes Zanzinger , Jürgen Czachurski , Bertram Offner , Horst Seller. Show more. Add to Mendeley. Share.

The online version of Neuroscience Letters at ScienceDirect.com, the world's leading platform for high quality peer-reviewed full-text journals.

7 Allgemeine Veröffentlichungen

— Johannes Zanzinger. Global Licensing. Cardiometabolic Diseases. Biberach, Germany. Phone: + Fax: + — Johannes Zanzinger. Global Licensing. Cardiometabolic Diseases. Biberach, Germany. Phone: + Fax: + ...

von J Zanzinger — Johannes Zanzinger &; Eberhard Bassenge. Chapter. 83 Accesses. Part of the book ... Johannes Zanzinger & Eberhard Bassenge. Authors. Johannes Zanzinger. View ... von J Zanzinger — Johannes Zanzinger &; Eberhard Bassenge. Chapter. 83 Accesses. Part of the book ... Johannes Zanzinger & Eberhard Bassenge. Authors. Johannes Zanzinger. View ...

von J Zanzinger · · Zitiert von: 2 — Johannes Zanzinger &; Eberhard Bassenge. 17 Accesses. 1 Citation. Explore ... Authors and Affiliations. I. Physiologisches Institut, Universität Heidelberg, ... von J Zanzinger · · Zitiert von: 2 — Johannes Zanzinger &; Eberhard Bassenge. 17 Accesses. 1 Citation. Explore ... Authors and Affiliations. I. Physiologisches Institut, Universität Heidelberg, ...

... development of tolerance during long-term infusion in dogs: role of the sulfhydryl moiety. By Johannes Zanzinger, Martin Feelisch and Eberhard Bassenge ...

4 Meinungen & Artikel

... Johannes Zanzinger, Global Head, BD & Licensing Cardiometabolic Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG; Joshua Resnick, Head of Merck Research Johannes Zanzinger, Global Head, BD & Licensing Cardiometabolic Diseases, Boehringer Ingelheim Pharma GmbH & Co. KG; Joshua Resnick, Head of Merck Research ...

Boehringer Ingelheim Day with MassBio 2:00 – 7:30pm MassBio and Catalyst restaurant at 300 Technology Square, Cambridge, MA October 8th, The...

... Development & Licensing in the same company in Johannes Zanzinger was trained in Animal Sciences and Biology at the University of Hohenheim in Germany, ... ›

118 Webfunde aus dem Netz

Johannes Zanzinger. Want to see more? Is it you? Update data. Investor info. Type Angel Investors Stage focus. Seed Round. Relevant investments. Company. Amount. Johannes Zanzinger. Want to see more? Is it you? Update data. Investor info. Type Angel Investors Stage focus. Seed Round. Relevant investments. Company. Amount.

Johannes Zanzinger. ScholarGPS™ ID: Affiliation. Pfizer Inc., New York, United States. Affiliation History. View. Field. Life Sciences. Johannes Zanzinger. ScholarGPS™ ID: Affiliation. Pfizer Inc., New York, United States. Affiliation History. View. Field. Life Sciences.

Johannes Zanzinger is currently a Director at Eyevensys SAS, Metabomed Ltd., HepaRegeniX GmbH, and DiogenX SAS. He is also an Investor at Boehringer ... Johannes Zanzinger is currently a Director at Eyevensys SAS, Metabomed Ltd., HepaRegeniX GmbH, and DiogenX SAS. He is also an Investor at Boehringer ...

— Raul Johannes Zanzinger er bl.a. associeret med virksomheden Raul Zanzinger Consulting. Se også eventuelle bestyrelses-poster og komplet — Raul Johannes Zanzinger er bl.a. associeret med virksomheden Raul Zanzinger Consulting. Se også eventuelle bestyrelses-poster og komplet ...

Fei Shen | Boehringer Ingelheim Venture Fund. Johannes Zanzinger | Boehringer Ingelheim Venture Fund. Hongmei Li | Boehringer Ingelheim Venture Fund. Load Fei Shen | Boehringer Ingelheim Venture Fund. Johannes Zanzinger | Boehringer Ingelheim Venture Fund. Hongmei Li | Boehringer Ingelheim Venture Fund. Load

... Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund. Johannes Zanzinger · Boehringer Ingelheim Venture Fund·Investor. Sweet spot: $8.5M. Range Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund. Johannes Zanzinger · Boehringer Ingelheim Venture Fund·Investor. Sweet spot: $8.5M. Range ...

von EE Johnson · · Zitiert von: 4 — Emma E Johnson , Helen Gibson, Beverley Nicol, Johannes Zanzinger, Peter Widdowson, Mark Hawthorn, Géza Toth, Judit Farkas, Remo Guerrini, David G Lambert ... von EE Johnson · · Zitiert von: 4 — Emma E Johnson , Helen Gibson, Beverley Nicol, Johannes Zanzinger, Peter Widdowson, Mark Hawthorn, Géza Toth, Judit Farkas, Remo Guerrini, David G Lambert ...

Boehringer Ingelheim Venture Fund. Yes. Series A - DiogenX Logo. Series A - DiogenX · Johannes Zanzinger · Roche Venture Fund Logo. Roche Venture Fund. —. Boehringer Ingelheim Venture Fund. Yes. Series A - DiogenX Logo. Series A - DiogenX · Johannes Zanzinger · Roche Venture Fund Logo. Roche Venture Fund. —.

— It is a potential breakthrough regenerative therapy aimed at restoring pancreatic function,” said Johannes Zanzinger, investment director at — It is a potential breakthrough regenerative therapy aimed at restoring pancreatic function,” said Johannes Zanzinger, investment director at ...

— ... Johannes Zanzinger, Investment Director at BIVF. “We are thrilled to continue our support of the DiogenX program in this important step — ... Johannes Zanzinger, Investment Director at BIVF. “We are thrilled to continue our support of the DiogenX program in this important step ...

Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Johannes Zanzinger,J. Czachurski,Horst Seller +2 moreHeidelberg ... Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Johannes Zanzinger,J. Czachurski,Horst Seller +2 moreHeidelberg ...

Johannes Zanzinger. Director · SP. Sebastian Pünzeler. Director · DS. David Shapiro. Advisor. Teams. DS. EP. EC. +5. Board of Directors. 8 members. Timeline. Johannes Zanzinger. Director · SP. Sebastian Pünzeler. Director · DS. David Shapiro. Advisor. Teams. DS. EP. EC. +5. Board of Directors. 8 members. Timeline.

Eyevensys's Founder, Chief Innovation Officer is Francine Behar-Cohen. Other executives include Johannes Zanzinger, Director; Patricia Zilliox, ... Eyevensys's Founder, Chief Innovation Officer is Francine Behar-Cohen. Other executives include Johannes Zanzinger, Director; Patricia Zilliox, ...

Johannes Zanzinger, Director. Patricia Zilliox, President and CEO. Dominik Escher, Director. Thierry Bordet. Johannes Zanzinger, Director. Patricia Zilliox, President and CEO. Dominik Escher, Director. Thierry Bordet.

... Johannes Zanzinger (1). Institute: (1)*I. Physiologisches Institut der Uni Heidelberg. Zeitschrift: Journal of Cardiovascular Pharmacology 1999: 33, Johannes Zanzinger (1). Institute: (1)*I. Physiologisches Institut der Uni Heidelberg. Zeitschrift: Journal of Cardiovascular Pharmacology 1999: 33,

von J Zanzinger · · Zitiert von: 73 — Johannes Zanzinger *. Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, CT13 9NJ England, UK. Abstract. The exact mechanisms by ... von J Zanzinger · · Zitiert von: 73 — Johannes Zanzinger *. Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent, CT13 9NJ England, UK. Abstract. The exact mechanisms by ...

von J Zanzinger · · Zitiert von: 73 — Author. Johannes Zanzinger. Affiliation. 1 Pfizer Global Research and Development, Sandwich Laboratoires, Sandwich, Kent, England, UK. Johannes_Zanzinger ... von J Zanzinger · · Zitiert von: 73 — Author. Johannes Zanzinger. Affiliation. 1 Pfizer Global Research and Development, Sandwich Laboratoires, Sandwich, Kent, England, UK. Johannes_Zanzinger ...

von J Zanzinger · · Zitiert von: 61 — Johannes Zanzinger; ,; Jürgen Czachurski; and; Horst Seller. Johannes Zanzinger. Johannes Zanzinger. From the I. Physiologisches Institut, Universität ... von J Zanzinger · · Zitiert von: 61 — Johannes Zanzinger; ,; Jürgen Czachurski; and; Horst Seller. Johannes Zanzinger. Johannes Zanzinger. From the I. Physiologisches Institut, Universität ...

von E Bassenge · · Zitiert von: 77 — Johannes Zanzinger. Johannes Zanzinger. Affiliations. From the Institute of Applied Physiology, Freiburg, Germany. Search for articles by this author. DOI:https ... von E Bassenge · · Zitiert von: 77 — Johannes Zanzinger. Johannes Zanzinger. Affiliations. From the Institute of Applied Physiology, Freiburg, Germany. Search for articles by this author. DOI:https ...

von J Zanzinger · · Zitiert von: 21 — Author: Johannes Zanzinger. Author: Martin Feelisch · ORCID iD. Author: Eberhard Bassenge. Download statistics. Downloads from ePrints over the past year. Other ... von J Zanzinger · · Zitiert von: 21 — Author: Johannes Zanzinger. Author: Martin Feelisch · ORCID iD. Author: Eberhard Bassenge. Download statistics. Downloads from ePrints over the past year. Other ...